Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00003622
Recruitment Status : Withdrawn (No recruitment)
First Posted : May 3, 2004
Last Update Posted : July 13, 2017
Information provided by (Responsible Party):
James Ahlgren, George Washington University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : May 2008
Actual Study Completion Date : February 22, 2017